Repurposing immunosuppressants for antileukemia therapy
Repurposing immunosuppressants for antileukemia therapy
About this item
Full title
Author / Creator
Publisher
England: EMBO Press
Journal title
Language
English
Formats
Publication information
Publisher
England: EMBO Press
Subjects
More information
Scope and Contents
Contents
Drug repurposing, the strategy to identify new therapeutic use for clinically approved drugs has attracted much attention in recent years. This strategy offers various advantages over traditional approaches to develop new drugs, including shorter development timelines, low cost, and reduced risk of failure. In this issue of EMBO Molecular Medicine,...
Alternative Titles
Full title
Repurposing immunosuppressants for antileukemia therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d147947120f44ee5b8299ec167e42a23
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d147947120f44ee5b8299ec167e42a23
Other Identifiers
ISSN
1757-4676
E-ISSN
1757-4684
DOI
10.15252/emmm.202217042
